CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.Bruce Ruggeri, Craig A. Dionne, Susan Jones‐Bolin et al.|PubMed|2003Cited by 124
Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a DerivativesMasami Kaneko, Chikara Murakata, Yutaka Saito et al.|Journal of Medicinal Chemistry|1997Cited by 120
A New Class of Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Structure−Activity Relationships for a Series of 9-Alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5-ones and the Identification of CEP-5214 and Its Dimethylglycine Ester Prodrug Clinical Candidate CEP-7055Diane E. Gingrich, Robert L. Hudkins, D. Rajagopala Reddy et al.|Journal of Medicinal Chemistry|2003Cited by 74
Enzyme-Linked Immunosorbent Assay for trkA Tyrosine Kinase ActivityThelma S. Angeles, Craig A. Dionne, Catherine Steffler et al.|Analytical Biochemistry|1996Cited by 42